Baseline NT-proBNP levels in Black and White patients with wild-type ATTR-CM reflect disease severity rather than inherent ...

GRAPEVINE, TX — Risk stratification of patients with chronic heart failure and a defibrillating cardiac resynchronization therapy (CRT-D) device may be improved by combining natriuretic peptide levels ...

LISBON, Portugal — Few people with suspected heart failure and elevated N-terminal prohormone of brain natriuretic peptide (NT-proBNP) levels are receiving a diagnosis after a year, reported ...

BOSTON, MA—Baseline levels of NT-proBNP, as well as early changes in levels of the biomarker, provide prognostic information among patients with severe tricuspid regurgitation (TR) undergoing ...

Please provide your email address to receive an email when new articles are posted on . Cancer survivors with increased NT-proBNP levels had an elevated risk for all-cause and cardiac mortality.

NT-proBNP is a cornerstone biomarker in the diagnosis and management of heart failure. Despite its widespread use, important biological and analytical challenges remain. One of the most significant is ...

PAH therapies improved hemodynamic parameters and reduced NT-proBNP levels in PH-ILD patients, indicating potential benefits. Precision medicine could help identify PH-ILD patients who may benefit ...

Patients with heart failure tended to have lower treatment intensity at hospital admission, but their cardiac load improved as blood pressure treatment intensified. Intensification of blood ...

LISBON, Portugal—Patients with suspected de novo heart failure (HF) presenting to outpatient centers are not undergoing echocardiography quickly enough to confirm the HF diagnosis, according to new ...